These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38183034)

  • 1. Lessons learned from annotation of VAERS reports on adverse events following influenza vaccination and related to Guillain-Barré syndrome.
    Sankaranarayanapillai M; Wang S; Ji H; Song HY; Tao C
    BMC Med Inform Decis Mak; 2024 Jan; 23(Suppl 4):298. PubMed ID: 38183034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome following influenza vaccination.
    Haber P; DeStefano F; Angulo FJ; Iskander J; Shadomy SV; Weintraub E; Chen RT
    JAMA; 2004 Nov; 292(20):2478-81. PubMed ID: 15562126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of post-vaccination Guillain-Barré syndrome using data from a passive surveillance system.
    Luo C; Jiang Y; Du J; Tong J; Huang J; Lo Re V; Ellenberg SS; Poland GA; Tao C; Chen Y
    Pharmacoepidemiol Drug Saf; 2021 May; 30(5):602-609. PubMed ID: 33533072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome.
    Miller ER; McNeil MM; Moro PL; Duffy J; Su JR
    Vaccine; 2020 Nov; 38(47):7458-7463. PubMed ID: 33039207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signals and trends of Guillain-Barré syndrome after the introduction of live-attenuated vaccines for influenza in the US and South Korean adverse event reporting systems.
    Lee H; Kim HJ; Choe YJ; Shin JY
    Vaccine; 2020 Jul; 38(34):5464-5473. PubMed ID: 32600907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccination and Guillain Barre syndrome.
    Geier MR; Geier DA; Zahalsky AC
    Clin Immunol; 2003 May; 107(2):116-21. PubMed ID: 12763480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracting postmarketing adverse events from safety reports in the vaccine adverse event reporting system (VAERS) using deep learning.
    Du J; Xiang Y; Sankaranarayanapillai M; Zhang M; Wang J; Si Y; Pham HA; Xu H; Chen Y; Tao C
    J Am Med Inform Assoc; 2021 Jul; 28(7):1393-1400. PubMed ID: 33647938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of the vaccine adverse event text mining system to the classification of possible Guillain-Barré syndrome reports.
    Botsis T; Woo EJ; Ball R
    Appl Clin Inform; 2013; 4(1):88-99. PubMed ID: 23650490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the Editor. Guillain-Barré Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004.
    Haber P; Slade B; Iskander J
    Vaccine; 2007 Nov; 25(48):8101. PubMed ID: 17933441
    [No Abstract]   [Full Text] [Related]  

  • 11. Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax(®)) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015.
    Moro PL; Winiecki S; Lewis P; Shimabukuro TT; Cano M
    Vaccine; 2015 Nov; 33(48):6684-8. PubMed ID: 26518405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.
    Haber P; Moro PL; Lewis P; Woo EJ; Jankosky C; Cano M
    Vaccine; 2016 May; 34(22):2507-12. PubMed ID: 27015735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System.
    Bardenheier BH; Duderstadt SK; Engler RJ; McNeil MM
    Vaccine; 2016 Aug; 34(37):4406-14. PubMed ID: 27449076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 - 2019.
    Moro PL; Woo EJ; Marquez P; Cano M
    Vaccine; 2020 Aug; 38(37):5923-5926. PubMed ID: 32709434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021.
    Woo EJ; Mba-Jonas A; Dimova RB; Alimchandani M; Zinderman CE; Nair N
    JAMA; 2021 Oct; 326(16):1606-1613. PubMed ID: 34617967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database.
    Kamath A; Maity N; Nayak MA
    Clin Drug Investig; 2020 Sep; 40(9):883-889. PubMed ID: 32696320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-possible stimulated reporting?
    McNeil MM; Arana J; Stewart B; Hartshorn M; Hrncir D; Wang H; Lamias M; Locke M; Stamper J; Tokars JI; Engler RJ
    Vaccine; 2012 Mar; 30(14):2421-6. PubMed ID: 22310205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013.
    Haber P; Moro PL; McNeil MM; Lewis P; Woo EJ; Hughes H; Shimabukuro TT
    Vaccine; 2014 Nov; 32(48):6499-504. PubMed ID: 25258101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022.
    Moro PL; Zhang B; Ennulat C; Harris M; McVey R; Woody G; Marquez P; McNeil MM; Su JR
    Vaccine; 2023 Mar; 41(11):1859-1863. PubMed ID: 36669964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reports of Guillain-Barre Syndrome Following COVID-19 Vaccination in the USA: An Analysis of the VAERS Database.
    Chalela JA; Andrews C; Bashmakov A; Kapoor N; Snelgrove D
    J Clin Neurol; 2023 Mar; 19(2):179-185. PubMed ID: 36854334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.